Literature DB >> 29952266

Short Antimicrobial Peptides.

Komal Sharma1, Shams Aaghaz1, Kitika Shenmar1, Rahul Jain1.   

Abstract

BACKGROUND: After the era of serendipitous discovery of penicillin and outburst in the discovery and development of highly efficient antibiotics, a surge in resistance against the target specific drugs was observed, primarily due to a combination of selective pressure of antibiotics use and spontaneous mutations. As per the World Health Organization, antibiotic resistance is one of the greatest threats to the mankind.
OBJECTIVE: Short antimicrobial peptides (SAMPs) can be considered as a viable therapeutic alternative to conventional antibiotics in tackling resistant microbes. The ubiquitous nature of SAMPs combined with their ability to act via non-specific modes of action, high activity against a wide spectrum of drug-sensitive and drug-resistant microbes, and relative insusceptibility against the development of resistance adds to their desirability as new generation antibiotics.
RESULTS: Due to the natural tendency of peptides to get metabolized by proteolytic enzymes, modification of naturally occurring SAMPs is desirable. The modifications can be done either by incorporating unnatural or modified amino acids into the peptide chain or by protecting C and N termini. The characteristic feature of SAMPs is their hydrophobicity and cationicity, which aid in the effective killing of microbes by selectively binding target and lysing the microbial cells with less deleterious effects on the host cells as compared to AMPs and other conventional antibiotics.
CONCLUSION: Herein, we discussed the arsenal of short peptides and peptidomimetics starting from the smallest unit possible - a dipeptide to a decapeptide along with their activity profiles as antimicrobials. Recently, various SAMPs have paved their ways from in vitro studies to clinical trials, as evident from the most recent patent (EP1951194) on oral hygiene. This step by step growth of SAMPs has restored the hope in peptide-based therapeutics, which may prove an essential tool in eradicating antimicrobial resistance and tackling various microbial infections. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Peptides; antibiotics; antimicrobial peptides; bacterial infections; drug resistance; sungal infections.

Mesh:

Substances:

Year:  2018        PMID: 29952266     DOI: 10.2174/1574891X13666180628105928

Source DB:  PubMed          Journal:  Recent Pat Antiinfect Drug Discov        ISSN: 1574-891X


  5 in total

1.  Antifungal potential of secondary metabolites involved in the interaction between citrus pathogens.

Authors:  Jonas Henrique Costa; Cristiane Izumi Wassano; Célio Fernando Figueiredo Angolini; Kirstin Scherlach; Christian Hertweck; Taícia Pacheco Fill
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

2.  Evaluation of a Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Supramolecular Hydrogel.

Authors:  Peter J Jervis; Loic Hilliou; Renato B Pereira; David M Pereira; José A Martins; Paula M T Ferreira
Journal:  Nanomaterials (Basel)       Date:  2021-03-11       Impact factor: 5.076

Review 3.  Marine Invertebrate Peptides: Antimicrobial Peptides.

Authors:  Ran Wu; Jiri Patocka; Eugenie Nepovimova; Patrik Oleksak; Martin Valis; Wenda Wu; Kamil Kuca
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

Review 4.  Natural and Synthetic Halogenated Amino Acids-Structural and Bioactive Features in Antimicrobial Peptides and Peptidomimetics.

Authors:  Mario Mardirossian; Marina Rubini; Mauro F A Adamo; Marco Scocchi; Michele Saviano; Alessandro Tossi; Renato Gennaro; Andrea Caporale
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

5.  Effect of Non-natural Hydrophobic Amino Acids on the Efficacy and Properties of the Antimicrobial Peptide C18G.

Authors:  Morgan A Hitchner; Matthew R Necelis; Devanie Shirley; Gregory A Caputo
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04       Impact factor: 4.609

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.